Suppr超能文献

103例复发性肝细胞癌腹腔镜再次肝切除病例回顾

Review of 103 Cases of Laparoscopic Repeat Liver Resection for Recurrent Hepatocellular Carcinoma.

作者信息

Goh Brian K P, Teo Jin-Yao, Chan Chung-Yip, Lee Ser-Yee, Cheow Peng-Chung, Chung Alexander Y F

机构信息

1 Department of Hepatopancreatobiliary and Transplantation Surgery, Singapore General Hospital , Singapore, Singapore .

2 Duke-National University of Singapore Medical School , Singapore, Singapore .

出版信息

J Laparoendosc Adv Surg Tech A. 2016 Nov;26(11):876-881. doi: 10.1089/lap.2016.0281. Epub 2016 Aug 25.

Abstract

INTRODUCTION

Laparoscopic repeat liver resection (LRLR) has been shown in small retrospective studies to be a safe and effective treatment for recurrent hepatocellular carcinoma (rHCC) in selected patients. The aim of this study was to perform a systematic review of the current literature to determine the safety, feasibility, and oncologic integrity of LRLR for rHCC.

METHODS

A computerized search of the PubMed database was performed for all English language studies evaluating LRLR for HCC from January 1, 2005 to March 31, 2016.

RESULTS

Ten studies reporting on 103 patients were included in this review. 30/51 (58.5%) patients had liver cirrhosis. In 66/95 (69.5%) patients, the index surgery was an open resection and this was a major hepatectomy in 8/49 (16.3%) patients. In 17/72 (23.6%) patients, LRLR was performed for tumors in the posterosuperior segments and in 21/60 (35%) for ipsilateral HCC recurrence. The median tumor size of rHCC ranged from 17-40 mm and 8/69 (11.6%) LRLR were for multifocal rHCC. In 100/103 (97%) patients LRLR was attempted via pure laparoscopy and 2 (1.9%) required open conversion. Median operation time of LRLR ranged from 73-343 minutes and the median blood loss ranged from 50 to 297 mL. The reported postoperative morbidity was 24/97 (24.7%) and there was no postoperative mortality. The median postoperative length of stay ranged from 3.5 to 11 days. Three studies compared the outcomes of LRLR versus open resection for rHCC and all three demonstrated a significant decrease in blood loss in favor of LRLR.

CONCLUSION

In highly selected patients; LRLR for rHCC is feasible and safe. LRLR can be performed for patients with previous open LR, previous major hepatectomy, two previous LR, multiple tumors, liver cirrhosis, ipsilateral HCC recurrence, and cancers located in the difficult posterosuperior segments. Comparative studies have demonstrated that LRLR is superior to open repeat liver resection in terms of perioperative outcomes such as decreased blood loss and length of stay.

摘要

引言

小型回顾性研究表明,腹腔镜下再次肝切除术(LRLR)对于部分特定患者复发性肝细胞癌(rHCC)是一种安全有效的治疗方法。本研究旨在对当前文献进行系统回顾,以确定LRLR治疗rHCC的安全性、可行性及肿瘤学完整性。

方法

对PubMed数据库进行计算机检索,纳入2005年1月1日至2016年3月31日期间所有评估LRLR治疗HCC的英文研究。

结果

本综述纳入了10项研究,共报道103例患者。51例患者中有30例(58.5%)患有肝硬化。95例患者中有66例(69.5%)首次手术为开放性肝切除术,其中49例患者中有8例(16.3%)进行了扩大肝切除术。72例患者中有17例(23.6%)因后上段肿瘤接受LRLR,60例患者中有21例(35%)因同侧HCC复发接受LRLR。rHCC的肿瘤大小中位数为17 - 40mm,69例患者中有8例(11.6%)LRLR用于多灶性rHCC。103例患者中有100例(97%)尝试通过单纯腹腔镜进行LRLR,2例(1.9%)需要转为开放手术。LRLR的中位手术时间为73 - 343分钟,中位失血量为50 - 297mL。报道的术后发病率为24/97(24.7%),无术后死亡病例。术后住院时间中位数为3.5 - 11天。三项研究比较了LRLR与开放性肝切除术治疗rHCC的结果,所有三项研究均表明LRLR的失血量显著减少。

结论

在经过严格筛选的患者中,LRLR治疗rHCC是可行且安全的。LRLR可用于既往接受过开放性肝切除术、既往接受过扩大肝切除术、既往接受过两次肝切除术、多肿瘤、肝硬化、同侧HCC复发以及位于困难的后上段的癌症患者。比较研究表明,LRLR在围手术期结果方面优于开放性再次肝切除术,如减少失血量和缩短住院时间。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验